ELI LILLY & Co Comprehensive Income 2007-2026 | LLY
Beta
What is comprehensive income?
Comprehensive income includes net income plus other comprehensive items like foreign currency adjustments and unrealized investment gains or losses.
What is ELI LILLY & Co's current comprehensive income?
ELI LILLY & Co (LLY) annual comprehensive income for 2025 was $22.08B, a 108.42% increase from 2024. ELI LILLY & Co comprehensive income for the quarter ending March 31, 2026 was $7.44B.
What was ELI LILLY & Co's comprehensive income in 2024?
ELI LILLY & Co annual comprehensive income for 2024 was $10.60B, a 122.68% increase from 2023.
What was ELI LILLY & Co's comprehensive income in 2023?
ELI LILLY & Co annual comprehensive income for 2023 was $4.76B, a 29.44% decline from 2022.
What is ELI LILLY & Co's 5-year comprehensive income CAGR?
ELI LILLY & Co comprehensive income grew at a compound annual growth rate (CAGR) of 28.84% from FY2020 to FY2025, going from $6.22B to $22.08B over 5 years.
Comprehensive Income History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Growing
CAGR+28.8%
FY2020
$6.22B
→
FY2025
$22.08B
07080910111213141516171819202122232425
5 years selected
Comprehensive Income History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $22.08B | +108.4% | 10-K |
| FY2024 | $10.60B | +122.7% | 10-K |
| FY2023 | $4.76B | -29.4% | 10-K |
| FY2022 | $6.74B | -12.8% | 10-K |
| FY2021 | $7.74B | +24.3% | 10-K |
| FY2020 | $6.22B | -17.4% | 10-K |
| FY2019 | $7.54B | +127.3% | 10-K |
| FY2018 | $3.32B | +11301.4% | 10-K |
| FY2017 | $-29.6M | -101.4% | 10-K |
| FY2016 | $2.09B | +15.0% | 10-K |
| FY2015 | $1.82B | +353.3% | 10-K |
| FY2014 | $401.4M | -93.8% | 10-K |
| FY2013 | $6.48B | +56.1% | 10-K |
| FY2012 | $4.15B | +31.4% | 10-K |
| FY2011 | $3.16B | -35.1% | 10-K |
| FY2010 | $4.87B | +4.9% | 10-K |
| FY2009 | $4.64B | +195.3% | 10-K |
| FY2008 | $-4.87B | -211.9% | 10-K |
| FY2007 | $4.35B | - | 10-K |
Company: ELI LILLY & CoTicker: LLYSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →